Cannabis: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 March 2024

21 March 2024

  • curprev 05:2105:21, 21 March 2024‎ Lazy talk contribs‎ 1,596 bytes −57‎ No edit summary
  • curprev 05:1805:18, 21 March 2024‎ Lazy talk contribs‎ 1,653 bytes +1,653‎ Created page with "{{TreatmentInfo |drug_name=Cannabis and Cannabis-derived Products (e.g., Sativex) |FDA_approval=Sativex is approved in Canada and some European countries for neuropathic pain; cannabis itself is not FDA-approved for cancer treatment |used_for=Investigational use in cancer treatment, including glioblastoma, for its direct anti-cancer and anti-nausea effects |clinical_trial_phase=Preclinical studies and early clinical trials, including a notable trial with Sativex for glio..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Cannabis"